HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin.

AbstractAIMS:
Punicalagin (PU) is one of the major ellagitannins found in the pomegranate (Punica granatum), which is a popular fruit with several health benefits. So far, no studies have evaluated the effects of PU on nonalcoholic fatty liver disease (NAFLD). Our work aims at studying the effect of PU-enriched pomegranate extract (PE) on high fat diet (HFD)-induced NAFLD.
RESULTS:
PE administration at a dosage of 150 mg/kg/day significantly inhibited HFD-induced hyperlipidemia and hepatic lipid deposition. As major contributors to NAFLD, increased expression of pro-inflammatory cytokines such as tumor necrosis factor-alpha, interleukins 1, 4, and 6 as well as augmented oxidative stress in hepatocytes followed by nuclear factor (erythroid-derived-2)-like 2 (Nrf2) activation were normalized through PE supplementation. In addition, PE treatment reduced uncoupling protein 2 (UCP2) expression, restored ATP content, suppressed mitochondrial protein oxidation, and improved mitochondrial complex activity in the liver. In contrast, mitochondrial content was not affected despite increased peroxisomal proliferator-activated receptor-gamma coactivator-1α (PGC-1α) and elevated expression of genes related to mitochondrial beta-oxidation after PE treatment. Finally, PU was identified as the predominant active component of PE with regard to the lowering of triglyceride and cholesterol content in HepG2 cells, and both PU- and PE-protected cells from palmitate induced mitochondrial dysfunction and insulin resistance.
INNOVATION:
Our work presents the beneficial effects of PE on obesity-associated NAFLD and multiple risk factors. PU was proposed to be the major active component.
CONCLUSIONS:
By promoting mitochondrial function, eliminating oxidative stress and inflammation, PU may be a useful nutrient for the treatment of NAFLD.
AuthorsXuan Zou, Chunhong Yan, Yujie Shi, Ke Cao, Jie Xu, Xun Wang, Cong Chen, Cheng Luo, Yuan Li, Jing Gao, Wentao Pang, Jialong Zhao, Fei Zhao, Hao Li, Adi Zheng, Wenyan Sun, Jiangang Long, Ignatius Man-Yau Szeto, Youyou Zhao, Zhizhong Dong, Peifang Zhang, Junkuan Wang, Wuyuan Lu, Yong Zhang, Jiankang Liu, Zhihui Feng
JournalAntioxidants & redox signaling (Antioxid Redox Signal) Vol. 21 Issue 11 Pg. 1557-70 (Oct 10 2014) ISSN: 1557-7716 [Electronic] United States
PMID24393106 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Hydrolyzable Tannins
  • Plant Extracts
  • Sterol Regulatory Element Binding Protein 1
  • Triglycerides
  • punicalagin
  • Cholesterol
Topics
  • Animals
  • Body Weight (drug effects)
  • Cholesterol (metabolism)
  • Diet, High-Fat
  • Disease Models, Animal
  • Hep G2 Cells
  • Humans
  • Hydrolyzable Tannins (pharmacology)
  • Inflammation (metabolism)
  • Insulin Resistance
  • Lipid Metabolism
  • Liver (drug effects, metabolism, pathology)
  • Lythraceae (chemistry)
  • Male
  • Mitochondria (drug effects, metabolism)
  • Non-alcoholic Fatty Liver Disease (blood, etiology, metabolism, pathology)
  • Obesity (complications, metabolism)
  • Oxidative Stress (drug effects)
  • Plant Extracts (chemistry, pharmacology)
  • Rats
  • Sterol Regulatory Element Binding Protein 1 (metabolism)
  • Triglycerides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: